Abstract
Abstract
Background
NSW has a multicultural population with increasing migration from South East Asia, the Western Pacific and Eastern Mediterranean.
Objective
To compare cancer stage, treatment (first 12 months) and survival for 12 country of birth (COB) categories recorded on the population-based NSW Cancer Registry.
Design
Historic cohort study of invasive breast cancers diagnosed in 2003–2016.
Patients
Data for 48,909 women (18+ ages) analysed using linked cancer registry, hospital inpatient and Medicare and pharmaceutical benefits claims data.
Measurement
Comparisons by COB using multivariate logistic regression and proportional hazards regression with follow-up of vital status to April 30th, 2020.
Results
Compared with the Australia-born, women born in China, the Philippines, Vietnam and Lebanon were younger at diagnosis, whereas those from the United Kingdom, Germany, Italy and Greece were older. Women born in China, the Philippines, Vietnam, Greece and Italy lived in less advantaged areas. Adjusted analyses indicated that: (1) stage at diagnosis was less localised for women born in Germany, Greece, Italy and Lebanon; (2) a lower proportion reported comorbidity for those born in China, the Philippines and Vietnam; (3) surgery type varied, with mastectomy more likely for women born in China, the Philippines and Vietnam, and less likely for women born in Italy, Greece and Lebanon; (4) radiotherapy was more likely where breast conserving surgery was more common (Greece, Italy, and Lebanon) and the United Kingdom; and (5) systemic drug therapy was less common for women born in China and Germany. Five-year survival in NSW was high by international standards and increasing. Adjusted analyses indicate that, compared with the Australian born, survival from death from cancer at 5 years from diagnosis was higher for women born in China, the Philippines, Vietnam, Italy, the United Kingdom and Greece.
Conclusions
There is diversity by COB of stage, treatment and survival. Reasons for survival differences may include cultural factors and healthier migrant populations with lower comorbidity, and potentially, less complete death recording in Australia if some women return to their birth countries for treatment and end-of-life care. More research is needed to explore the cultural and clinical factors that health services need to accommodate.
Funder
National Breast Cancer Foundation
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference34 articles.
1. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analyses of individual records of 37,513,025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;39(10125):1023–75.
2. Australian Institute of Health and Welfare (AIHW). Cancer in Australia 2019. Cancer series no.119. Cat. no. CAN 123. Canberra: Australian Institute of Health and Welfare; 2019.
3. Australian Institute of Health and Welfare (AIHW). Breast cancer survival in Australian women 1982–1994. Cancer Series No. 9, AIHW cat. No. CAN 4. Canberra: AIHW; 1998. https://www.aihw.gov.au/reports/cancer/breast-cancer-survival-in-australian-women-1982-94/contents/table-of-contents. Accessed 13 Apr 2020
4. Australian Institute of Health and Welfare (AIHW). Cancer data in Australia. Canberra: AIHW; 2020. https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia. Accessed 15 Apr 2020
5. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer observatory: Cancer today. Lyon: International Agency for Research on Cancer; 2018. https://gco.iarc.fr/today. Accessed 20 Apr 2020